{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:14:16Z","timestamp":1761902056492,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008974","name":"University of Social Welfare and Rehabilitation Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.msard.2022.104076","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T02:47:47Z","timestamp":1659235667000},"page":"104076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protective effects of Herbal Compound (IM253) on the inflammatory responses and oxidative stress in a mouse model of multiple sclerosis"],"prefix":"10.1016","volume":"67","author":[{"given":"Emran","family":"Esmaeilzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Khorram Khorshid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.msard.2022.104076_bib0001","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/glia.20806","article-title":"17\u03b2-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice","volume":"57","author":"Acs","year":"2009","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.msard.2022.104076_bib0002","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","article-title":"Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases","volume":"41","author":"Aggarwal","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.msard.2022.104076_bib0003","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaut.2011.06.003","article-title":"Distinct pathological patterns in relapsing\u2013remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate","volume":"37","author":"Aharoni","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.msard.2022.104076_bib0004","unstructured":"Baghaei, A., et\u00a0al., Efficacy of Setarud (IMOD\u00ae), a novel drug with potent anti-toxic stress potential in rat inflammatory bowel disease and comparison with dexamethasone and infliximab.2010."},{"issue":"3","key":"10.1016\/j.msard.2022.104076_bib0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.15171\/apb.2017.060","article-title":"Effects of Herbal Compound (IMOD) on Behavior and Expression of Alzheimer\u2019s Disease Related Genes in Streptozotocin-Rat Model of Sporadic Alzheimer\u2019s Disease","volume":"7","author":"Bazazzadegan","year":"2017","journal-title":"Adv. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.msard.2022.104076_bib0006","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: AT cell\u2013derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology"},{"issue":"3","key":"10.1016\/j.msard.2022.104076_bib0007","first-page":"120","article-title":"Neuroprotective effects of herbal extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on rat model of sporadic Alzheimer\u2019s disease","volume":"8","author":"Daneshmand","year":"2016","journal-title":"Avicenna J. Med. Biotechnol."},{"issue":"8","key":"10.1016\/j.msard.2022.104076_bib0008","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s11064-013-1061-9","article-title":"Shikonin protects dopaminergic cell line PC12 against 6-hydroxydopamine-mediated neurotoxicity via both glutathione-dependent and independent pathways and by inhibiting apoptosis","volume":"38","author":"Esmaeilzadeh","year":"2013","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.msard.2022.104076_bib0009","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ddr.21540","article-title":"Curcumin ameliorates experimental autoimmune encephalomyelitis in a C57BL\/6 mouse model","volume":"80","author":"Esmaeilzadeh","year":"2019","journal-title":"Drug Dev. Res."},{"issue":"3","key":"10.1016\/j.msard.2022.104076_bib0010","first-page":"S18","article-title":"A review of possible herbal treatment in multiple sclerosis in traditional persian medicine","volume":"41","author":"Ghanavati","year":"2016","journal-title":"Iran. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.msard.2022.104076_bib0011","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1357-4310(99)01639-1","article-title":"Animal models for autoimmune demyelinating disorders of the nervous system","volume":"6","author":"Gold","year":"2000","journal-title":"Mol. Med. Today"},{"issue":"8","key":"10.1016\/j.msard.2022.104076_bib0012","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1191\/0269215503cr688oa","article-title":"Assessing mood in patients with multiple sclerosis","volume":"17","author":"Groom","year":"2003","journal-title":"Clin. Rehabil."},{"issue":"3-4","key":"10.1016\/j.msard.2022.104076_bib0013","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000119879","article-title":"Optic nerve degeneration in experimental autoimmune encephalomyelitis","volume":"40","author":"Guy","year":"2008","journal-title":"Ophthalmic Res."},{"issue":"11","key":"10.1016\/j.msard.2022.104076_bib0014","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+ CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2022.104076_bib0015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1186\/1742-2094-10-120","article-title":"Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model","volume":"10","author":"Horstmann","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.msard.2022.104076_bib0016","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/1352458508088918","article-title":"Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone\u00ae)","volume":"14","author":"Iarlori","year":"2008","journal-title":"Mult. Scler. J."},{"issue":"4","key":"10.1016\/j.msard.2022.104076_bib0017","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00415-005-0037-3","article-title":"Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis","volume":"253","author":"Koch","year":"2006","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2022.104076_bib0018","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2022.104076_bib0019","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1471-4159.2007.04506.x","article-title":"Inhibition of the myosin light chain kinase prevents hypoxia-induced blood\u2013brain barrier disruption","volume":"102","author":"Kuhlmann","year":"2007","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.msard.2022.104076_bib0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.104076_bib0021","doi-asserted-by":"crossref","first-page":"11783","DOI":"10.3390\/ijms130911783","article-title":"Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters","volume":"13","author":"Lee","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2022.104076_bib0022","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.msard.2022.104076_bib0023","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00005-017-0458-6","article-title":"Effects of IFN-\u03b21a and IFN-\u03b21b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis","volume":"65","author":"Lubina-D\u0105browska","year":"2017","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"issue":"1","key":"10.1016\/j.msard.2022.104076_bib0024","first-page":"23","article-title":"Examination of Setarud (IMOD\u2122) in the management of patients with severe sepsis","volume":"18","author":"Mahmoodpoor","year":"2010","journal-title":"Daru: journal of Faculty of Pharmacy, Tehran University of Medical Sciences"},{"key":"10.1016\/j.msard.2022.104076_bib0025","series-title":"Transforming growth factor-beta: recent advances on its role in immune tolerance, in Suppression and Regulation of Immune Responses","first-page":"303","author":"Mantel","year":"2010"},{"issue":"6-7","key":"10.1016\/j.msard.2022.104076_bib0026","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.neuropharm.2009.02.007","article-title":"TGF-\u03b2 as a promising option in the treatment of multiple sclerosis","volume":"56","author":"Mirshafiey","year":"2009","journal-title":"Neuropharmacology"},{"volume":"17","year":"2009","author":"Mohraz","key":"10.1016\/j.msard.2022.104076_bib0027"},{"issue":"3","key":"10.1016\/j.msard.2022.104076_bib0028","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.0953-816x.2000.01412.x","article-title":"LPS\/IFN-\u03b3 cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10","volume":"13","author":"Molina-Holgado","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2022.104076_bib0029","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2377-12-95","article-title":"TH1\/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab","volume":"12","author":"Oreja-Guevara","year":"2012","journal-title":"BMC Neurology"},{"issue":"1","key":"10.1016\/j.msard.2022.104076_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0733-8619(18)30061-6","article-title":"The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis","volume":"13","author":"Owens","year":"1995","journal-title":"Neurol. Clin."},{"issue":"1","key":"10.1016\/j.msard.2022.104076_bib0031","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2249.2000.01175.x","article-title":"Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-\u03b1)-and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-\u03b2) treatment","volume":"120","author":"\u00d6zenci","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2022.104076_bib0032","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/157489112799829756","article-title":"Safety and efficacy of Setarud (IMOD TM) among people living with HIV\/AIDS: a review","volume":"7","author":"Paydary","year":"2012","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"issue":"12","key":"10.1016\/j.msard.2022.104076_bib0033","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.4103\/1673-5374.195273","article-title":"The role of interleukin-6 in central nervous system demyelination","volume":"11","author":"Petkovi\u0107","year":"2016","journal-title":"Neural Regen. Res."},{"issue":"1-2","key":"10.1016\/j.msard.2022.104076_bib0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02740619","article-title":"The effects of interferon-\u03b3 on the central nervous system","volume":"14","author":"Popko","year":"1997","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.msard.2022.104076_bib0035","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.0903853","article-title":"Regulation of Th1 and Th17 cell differentiation and amelioration of experimental autoimmune encephalomyelitis by natural product compound berberine","author":"Qin","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2022.104076_bib0037","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5115\/acb.2012.45.3.141","article-title":"Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages","volume":"45","author":"Shin","year":"2012","journal-title":"Anat. Cell Biol."},{"issue":"4","key":"10.1016\/j.msard.2022.104076_bib0038","first-page":"203","article-title":"Effects of Coenzyme Q10 on the ratio of TH1\/TH2 in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in C57BL\/6","volume":"18","author":"Soleimani","year":"2014","journal-title":"Iran. Biomed. J."},{"issue":"36","key":"10.1016\/j.msard.2022.104076_bib0039","doi-asserted-by":"crossref","first-page":"E5038","DOI":"10.1073\/pnas.1505955112","article-title":"IFN-\u03b3 ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation","volume":"112","author":"Sosa","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"year":"1996","series-title":"Glutathione peroxidase: activity and steady-state level of mRNA","author":"St Clair","key":"10.1016\/j.msard.2022.104076_bib0040"},{"issue":"1-2","key":"10.1016\/j.msard.2022.104076_bib0041","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-5728(93)90178-2","article-title":"Tumor necrosis factor-\u03b1 in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system","volume":"45","author":"Stoll","year":"1993","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.msard.2022.104076_bib0042","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjms.2018.08.018","article-title":"The properties of cytokines in multiple sclerosis: pros and cons","volume":"356","author":"Wang","year":"2018","journal-title":"Am. J. Med. Sci."},{"issue":"8","key":"10.1016\/j.msard.2022.104076_bib0043","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/096120300678828703","article-title":"Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus","volume":"9","author":"Wong","year":"2000","journal-title":"Lupus"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822005843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822005843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:06:32Z","timestamp":1761901592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822005843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":42,"alternative-id":["S2211034822005843"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.104076","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of Herbal Compound (IM253) on the inflammatory responses and oxidative stress in a mouse model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.104076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104076"}}